Marvel Biosciences Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Marvel Biosciences Corp. generated cash of -$1,179,496, which is more than the previous year. Cash used in financing activities reached the amount of $968,643 last year. Net change in cash is therefore -$210,853.
Cash Flow
| 2019 | -41.80K | -409K | 457.03K |
|---|---|---|---|
| 2020 | -538.53K | 0 | 763.17K |
| 2021 | -1.37M | 381.57K | 3.15M |
| 2022 | -2.19M | 0 | 394K |
| 2023 | -1.33M | 0 | 1.29M |
| 2024 | -1.17M | 0 | 968.64K |
MRVL.V Cash Flow Statement (2019 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 556.62K | 593.20K | 2.39M | 224.81K | 171 | 0 |
Operating activities | ||||||
Net income | -1.65M | -2.29M | -2.55M | -3.03M | -955.65K | -98.04K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 0 | 0 | 152 | 185 | 413 | 0 |
Stock-based compensation expense | 75.72K | 80.11K | 0 | 0 | 384.44K | 0 |
| Deferred income tax benefit | 75.72K | 80.11K | 0 | 0 | 384.44K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 4.23K | 0 | 2.66K | -23.26K | -35.84K | -2.00K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -1.17M | -1.33M | -2.19M | -1.37M | -538.53K | -41.80K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -409K |
Investments In Property Plant And Equipment | 0 | 5 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 381.57K | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 381.57K | 0 | -409K |
Financing activities | ||||||
Common Stock Issued | 500K | 270K | 420K | 3.18M | 758.42K | 457.03K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 500K | 1M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 968.64K | 1.29M | 394K | 3.15M | 763.17K | 457.03K |
Net Change In Cash | -210.85K | -36.58K | -1.79M | 2.16M | 224.63K | 6.23K |
Cash at end of period | 345.76K | 556.62K | 593.20K | 2.39M | 224.81K | 6.23K |